Dermatologists, melanoma and the law

References

• Studdert DM, Mello MM, Sage WM et al. Defensive medicine among high-risk specialist physicians in a volatile malpractice environment. JAMA293(21), 2609–2617 (2005).
   PubMed Web of Science ®Google Scholar
• Malpractice survey snapshot. Who’s been sued – and who won. Med. Econ.76(14), 58–60, 65, 69 (1999).
   Google Scholar
• Read S, Hill HF 3rd. Dermatology’s malpractice experience: clinical settings for risk management. J. Am. Acad. Dermatol.53(1), 134–137 (2005).
   PubMed Web of Science ®Google Scholar
• Lydiatt DD. Medical malpractice and cancer of the skin. Am. J. Surg.187(6), 688–694 (2004).
   PubMed Web of Science ®Google Scholar
• Prosser & Keeton on the Law of Torts. Keeton P, Prosser WL. (Eds). West Pub. Co., St. Paul, MN, USA (1984).
   Google Scholar
• Hall v. Hilburn, 466 So.2d 856, 873 (MS. 1985).
   Google Scholar
• Feit NE, Dusza SW, Marghoob AA. Melanomas detected with the aid of total cutaneous photography. Br. J. Dermatol.150(4), 706–714 (2004).
   PubMed Web of Science ®Google Scholar
• Kelly JW, Yeatman JM, Regalia C, Mason G, Henham AP. A high incidence of melanoma found in patients with multiple dysplastic naevi by photographic surveillance. Med. J. Aust.167(4), 191–194 (1997).
   PubMed Web of Science ®Google Scholar
• Masri GD, Clark WH Jr, Guerry D 4th, Halpern A, Thompson CJ, Elder DE. Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J. Am. Acad. Dermatol.22(6 Pt 1), 1042–1048 (1990).
   PubMed Web of Science ®Google Scholar
• Rivers JK, Kopf AW, Vinokur AF et al. Clinical characteristics of malignant melanomas developing in persons with dysplastic nevi. Cancer65(5), 1232–1236 (1990).
   PubMed Web of Science ®Google Scholar
• Mello MM. Of swords and shields: the role of clinical practice guidelines in medical malpractice litigation. U. Pa. L. Rev.149, 645 (2001).
   Web of Science ®Google Scholar
• The T.J. Hooper, 60 F.2d 737 (2d Cir. 1932).
   Google Scholar
• Epstein RA. Torts. Aspen Law & Business, Gaithersburg, MD, USA (1999).
   Google Scholar
• Frye v. U.S., 293 F. 1013 (D.C.Cir. 1923).
   Google Scholar
• Daubert v. Merrell Dow Parmaceuticals, Inc., 509 U.S. 579 (S.Ct. 1993).
   Google Scholar
• Kumho Tire Co., Ltd. v. Carmichael, 526 U.S. 137 (S.Ct. 1999).
   Google Scholar
• Reisig RA Jr. The Loss of Chance Theory in Medical Malpractice Cases: an Overview. Am. J. Trial Advoc.1163 (1990).
   Google Scholar
• Lipsker D, Engel F, Cribier B, Velten M, Hedelin G. Trends in melanoma epidemiology suggest three different types of melanoma. Br. J. Dermatol.157(2), 338–343 (2007).
   PubMed Web of Science ®Google Scholar
• Lipsker D. Growth rate, early detection, and prevention of melanoma: melanoma epidemiology revisited and future challenges. Arch. Dermatol.142(12), 1638–1640 (2006).
   PubMedGoogle Scholar
• Ferrara G, Zalaudek I, Di Stefani A, Soyer HP, Argenziano G. Do we detect a new spectrum of biologically ‘benign’ melanomas in the dermoscopy era? Melanoma Res.14(6), 567–568 (2004).
   PubMed Web of Science ®Google Scholar
• Berwick M. Evaluating early detection in the diagnosis of melanoma. Arch. Dermatol.142, 1485–1486 (2006).
   PubMedGoogle Scholar
• Baade PD, English DR, Youl PH, McPherson M, Elwood JM, Aitken JF. The relationship between melanoma thickness and time to diagnosis in a large population-based study. Arch. Dermatol.142(11), 1422–1427 (2006).
   PubMed Web of Science ®Google Scholar
• Brochez L, Verhaeghe E, Bleyen L, Naeyaert JM. Time delays and related factors in the diagnosis of cutaneous melanoma. Eur. J. Cancer37(7), 843–848 (2001).
   PubMed Web of Science ®Google Scholar
• Krige JE, Isaacs S, Hudson DA, King HS, Strover RM, Johnson CA. Delay in the diagnosis of cutaneous malignant melanoma. A prospective study in 250 patients. Cancer68(9), 2064–2068 (1991).
   PubMed Web of Science ®Google Scholar
• Liu W, Dowling JP, Murray WK et al. Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. Arch. Dermatol.142(12), 1551–1558 (2006).
   PubMed Web of Science ®Google Scholar
• Rustad M, Koenig T. Reconceptualizing Punitive Damages in Medical Malpractice: Targeting Amoral Corporations, Not ‘Moral Monsters’. Rutgers L. R.47, 975 (1995).
   Google Scholar
• Bleyer A, Viny A, Barr R. Cancer in 15- to 29-year-olds by primary site. Oncologist11(6), 590–601 (2006).
   PubMed Web of Science ®Google Scholar
• Lydiatt DD. Cancer of the oral cavity and medical malpractice. Laryngoscope112(5), 816–819 (2002).
   PubMed Web of Science ®Google Scholar
• Broder IE. Characteristics of Million Dollar Awards: Jury Verdicts and Final Disbursements. Just. Sys. J.349. (1986).
   Web of Science ®Google Scholar
• Fabre v. Marin, 623 So.2d 1182 (Fla. 1993).
   Google Scholar
• Apple JG, Deyling RP. A Primer on the Civil-Law System. Federal Judicial Center, (1995).
   Google Scholar
• Clermont KM, Sherwin E. A Comparative Vew of Standards of Proof. Am. J. Comp. L.50, 243 (2002).
   Web of Science ®Google Scholar
• Davis WK. The international view of attorney fees in civil suits: why is the united states the ‘odd man out’ in how it pays its lawyers? Ariz. J. Int’l & Comp. L.16, 361 (1999).
   Google Scholar
• Rigel DS, Friedman RJ, Kopf AW et al. Importance of complete cutaneous examination for the detection of malignant melanoma. J. Am. Acad. Dermatol.14(5 Pt 1), 857–860 (1986).
   PubMed Web of Science ®Google Scholar
• Marghoob AA, Scope A. The complexity of diagnosing melanoma. J. Invest. Dermatol.129(1), 11–13 (2009).
   PubMed Web of Science ®Google Scholar
• Zalaudek I, Kittler H, Marghoob AA et al. Time required for a complete skin examination with and without dermoscopy: a prospective, randomized multicenter study. Arch. Dermatol.144(4), 509–513 (2008).
   PubMedGoogle Scholar
• Grin CM, Kopf AW, Welkovich B, Bart RS, Levenstein MJ. Accuracy in the clinical diagnosis of malignant melanoma. Arch. Dermatol.126(6), 763–766 (1990).
   PubMedGoogle Scholar
• Morton CA, Mackie RM. Clinical accuracy of the diagnosis of cutaneous malignant melanoma. Br. J. Dermatol.138(2), 283–287 (1998).
   PubMed Web of Science ®Google Scholar
• Witheiler DD, Cockerell CJ. Histologic features and sensitivity of diagnosis of clinically unsuspected cutaneous melanoma. Am. J. Dermatopathol.13(6), 551–556 (1991).
   PubMed Web of Science ®Google Scholar
• Bafounta ML, Beauchet A, Aegerter P, Saiag P. Is dermoscopy (epiluminescence microscopy) useful for the diagnosis of melanoma? results of a meta-analysis using techniques adapted to the evaluation of diagnostic tests. Arch. Dermatol.137(10), 1343–1350 (2001).
   PubMedGoogle Scholar
• Kittler H, Pehamberger H, Wolff K, Binder M. Diagnostic accuracy of dermoscopy. Lancet Oncol.3(3), 159–165 (2002).
   PubMed Web of Science ®Google Scholar
• Troxel DB. Pitfalls in the diagnosis of malignant melanoma: findings of a risk management panel study. Am. J. Surg. Pathol.27(9), 1278–1283 (2003).
   PubMed Web of Science ®Google Scholar
• Bergenmar M, Ringborg U, Mansson Brahme E, Brandberg Y. Nodular histogenetic type – the most significant factor for thick melanoma: implications for prevention. Melanoma Res.8(5), 403–411 (1998).
   PubMed Web of Science ®Google Scholar
• Demierre MF, Chung C, Miller DR, Geller AC. Early detection of thick melanomas in the United States: beware of the nodular subtype. Arch. Dermatol.141(6), 745–750 (2005).
   PubMedGoogle Scholar
• Chamberlain AJ, Fritschi L, Giles GG, Dowling JP, Kelly JW. Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia. Arch. Dermatol.138(5), 609–614 (2002).
   PubMedGoogle Scholar
• Chamberlain AJ, Fritschi L, Kelly JW. Nodular melanoma: patients’ perceptions of presenting features and implications for earlier detection. J. Am. Acad. Dermatol.48(5), 694–701 (2003).
   PubMed Web of Science ®Google Scholar
• Betti R, Vergani R, Tolomio E, Santambrogio R, Crosti C. Factors of delay in the diagnosis of melanoma. Eur. J. Dermatol.13(2), 183–188 (2003).
   PubMed Web of Science ®Google Scholar
• Kelly JW. Nodular melanoma: how current approaches to early detection are failing. J. Drugs Dermatol.4(6), 790–793 (2005).
   PubMedGoogle Scholar
• Moynihan GD. The 3 Cs of melanoma: time for a change? J. Am. Acad. Dermatol.30(3), 510–511 (1994).
   PubMedGoogle Scholar
• Abbasi NR, Shaw HM, Rigel DS et al. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA292(22), 2771–2776 (2004).
   PubMed Web of Science ®Google Scholar
• Swetter SM, Soon S, Harrington CR, Chen SC. Effect of health care delivery models on melanoma thickness and stage in a university-based referral center: an observational pilot study. Arch. Dermatol.143(1), 30–36 (2007).
   PubMedGoogle Scholar
• Scope A, Dusza SW, Halpern AC et al. The ‘ugly duckling’ sign: agreement between observers. Arch. Dermatol.144(1), 58–64 (2008).
   PubMedGoogle Scholar
• Sondergaard K. Biological behaviour of cutaneous malignant melanomas. Pathology17(2), 255–257 (1985).
   PubMed Web of Science ®Google Scholar
• Bergenmar M, Hansson J, Brandberg Y. Detection of nodular and superficial spreading melanoma with tumour thickness < or = 2.0 mm: an interview study. Eur. J. Cancer Prev.11(1), 49–55 (2002).
   PubMed Web of Science ®Google Scholar
• Bono A, Maurichi A, Moglia D et al. Clinical and dermatoscopic diagnosis of early amelanotic melanoma. Melanoma Res.11(5), 491–494 (2001).
   PubMed Web of Science ®Google Scholar
• Bowling J, Argenziano G, Azenha A et al. Dermoscopy key points: recommendations from the international dermoscopy society. Dermatology214(1), 3–5 (2007).
   PubMed Web of Science ®Google Scholar
• Puig S, Argenziano G, Zalaudek I et al. Melanomas that failed dermoscopic detection: a combined clinicodermoscopic approach for not missing melanoma. Dermatol. Surg.33(10), 1262–1273 (2007).
   PubMed Web of Science ®Google Scholar
• Argenziano G, Zalaudek I, Ferrara G et al. Dermoscopy features of melanoma incognito: indications for biopsy. J. Am. Acad. Dermatol.56(3), 508–513 (2007).
   PubMed Web of Science ®Google Scholar
• Lodha S, Saggar S, Celebi JT, Silvers DN. Discordance in the histopathologic diagnosis of difficult melanocytic neoplasms in the clinical setting. J. Cutan. Pathol.35(4), 349–352 (2008).
   PubMed Web of Science ®Google Scholar
• Brochez L, Verhaeghe E, Grosshans E et al. Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions. J. Pathol.196(4), 459–466 (2002).
   PubMed Web of Science ®Google Scholar
• Corona R, Mele A, Amini M et al. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J. Clin. Oncol.14(4), 1218–1223 (1996).
   PubMed Web of Science ®Google Scholar
• Farmer ER, Gonin R, Hanna MP. Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum. Pathol.27(6), 528–531 (1996).
   PubMed Web of Science ®Google Scholar
• Molenkamp BG, Sluijter BJ, Oosterhof B, Meijer S, van Leeuwen PA. Non-radical diagnostic biopsies do not negatively influence melanoma patient survival. Ann. Surg. Oncol.14(4), 1424–1430 (2007).
   PubMed Web of Science ®Google Scholar
• Bong JL, Herd RM, Hunter JA. Incisional biopsy and melanoma prognosis. J. Am. Acad. Dermatol.46(5), 690–694 (2002).
   PubMed Web of Science ®Google Scholar
• Karimipour DJ, Schwartz JL, Wang TS et al. Microstaging accuracy after subtotal incisional biopsy of cutaneous melanoma. J. Am. Acad. Dermatol.52(5), 798–802 (2005).
   PubMed Web of Science ®Google Scholar
• Ng PC, Barzilai DA, Ismail SA, Averitte RL Jr, Gilliam AC. Evaluating invasive cutaneous melanoma: is the initial biopsy representative of the final depth? J. Am. Acad. Dermatol.48(3), 420–424 (2003).
   PubMed Web of Science ®Google Scholar
• Lederman JS, Sober AJ. Does wide excision as the initial diagnostic procedure improve prognosis in patients with cutaneous melanoma? J. Dermatol. Surg. Oncol.12(7), 697–699 (1986).
   PubMedGoogle Scholar
• McKenna DB, Lee RJ, Prescott RJ, Doherty VR. The time from diagnostic excision biopsy to wide local excision for primary cutaneous malignant melanoma may not affect patient survival. Br. J. Dermatol.147(1), 48–54 (2002).
   PubMed Web of Science ®Google Scholar
• Martin RC, 2nd, Scoggins CR, Ross MI et al. Is incisional biopsy of melanoma harmful? Am. J. Surg.190(6), 913–917 (2005).
   PubMed Web of Science ®Google Scholar
• Griffiths RW, Briggs JC. Biopsy procedures, primary wide excisional surgery and long term prognosis in primary clinical stage I invasive cutaneous malignant melanoma. Ann. R. Coll. Surg. Engl.67(2), 75–78 (1985).
   PubMed Web of Science ®Google Scholar
• Lees VC, Briggs JC. Effect of initial biopsy procedure on prognosis in stage 1 invasive cutaneous malignant melanoma: review of 1086 patients. Br. J. Surg.78(9), 1108–1110 (1991).
   PubMed Web of Science ®Google Scholar
• Somach SC, Taira JW, Pitha JV, Everett MA. Pigmented lesions in actinically damaged skin. Histopathologic comparison of biopsy and excisional specimens. Arch. Dermatol.132(11), 1297–1302 (1996).
   PubMedGoogle Scholar
• Glusac EJ. Under the microscope: doctors, lawyers, and melanocytic neoplasms. J. Cutan. Pathol.30(5), 287–293 (2003).
   PubMed Web of Science ®Google Scholar
• Balch CM, Soong SJ, Gershenwald JE et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J. Clin. Oncol.19(16), 3622–3634 (2001).
   PubMed Web of Science ®Google Scholar
• MacKie RM, Bray CA, Hole DJ et al. Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet360(9333), 587–591 (2002).
   PubMed Web of Science ®Google Scholar
• Tripp JM, Kopf AW, Marghoob AA, Bart RS. Management of dysplastic nevi: a survey of fellows of the American Academy of Dermatology. J. Am. Acad. Dermatol.46(5), 674–682 (2002).
   PubMed Web of Science ®Google Scholar
• Dyson SW, Bass J, Pomeranz J, Jaworsky C, Sigel J, Somach S. Impact of thorough block sampling in the histologic evaluation of melanomas. Arch. Dermatol.141(6), 734–736 (2005).
   PubMedGoogle Scholar
• Breslow A. Problems in the measurement of tumor thickness and level of invasion in cutaneous melanoma. Hum. Pathol.8(1), 1–2 (1977).
   PubMed Web of Science ®Google Scholar
• Yadav S, Vossaert KA, Kopf AW, Silverman M, Grin-Jorgensen C. Histopathologic correlates of structures seen on dermoscopy (epiluminescence microscopy). Am. J. Dermatopathol.15(4), 297–305 (1993).
   PubMed Web of Science ®Google Scholar
• Braun RP, Kaya G, Masouye I, Krischer J, Saurat JH. Histopathologic correlation in dermoscopy: a micropunch technique. Arch. Dermatol.139(3), 349–351 (2003).
   PubMedGoogle Scholar
• Soyer HP, Kenet RO, Wolf IH, Kenet BJ, Cerroni L. Clinicopathological correlation of pigmented skin lesions using dermoscopy. Eur. J. Dermatol.10(1), 22–28 (2000).
   PubMed Web of Science ®Google Scholar
• Soyer HP, Massone C, Ferrara G, Argenziano G. Limitations of histopathologic analysis in the recognition of melanoma: a plea for a combined diagnostic approach of histopathologic and dermoscopic evaluation. Arch. Dermatol.141(2), 209–211 (2005).
   PubMedGoogle Scholar
• Bolognia JL, Lin A, Shapiro PE. The significance of eccentric foci of hyperpigmentation (‘small dark dots’) within melanocytic nevi. Analysis of 59 cases. Arch. Dermatol.130(8), 1013–1017 (1994).
   PubMedGoogle Scholar
• Park HK, Leonard DD, Arrington JH 3rd, Lund HZ. Recurrent melanocytic nevi: clinical and histologic review of 175 cases. J. Am. Acad. Dermatol.17(2 Pt 1), 285–292 (1987).
   PubMed Web of Science ®Google Scholar
• Botella-Estrada R, Nagore E, Sopena J et al. Clinical, dermoscopy and histological correlation study of melanotic pigmentations in excision scars of melanocytic tumours. Br. J. Dermatol.154(3), 478–484 (2006).
   PubMed Web of Science ®Google Scholar
• Marghoob AA, Korzenko A. Recurrent (persistent) nevi. In: Atlas of Dermoscopy. Marghoob AA, Braun RP, Kopf AW (Eds). Taylor & Francis, NY, USA (2005).
   Google Scholar
• Spatz A, Ruiter D, Hardmeier T et al. Melanoma in childhood: an EORTC-MCG multicenter study on the clinico–pathological aspects. Int. J. Cancer68(3), 317–324 (1996).
   PubMed Web of Science ®Google Scholar
• Barnhill RL. The Spitzoid lesion: rethinking Spitz tumors, atypical variants, ‘Spitzoid melanoma’ and risk assessment. Mod. Pathol.19(Suppl. 2), S21–S33 (2006).
   PubMed Web of Science ®Google Scholar
• Crotty KA, McCarthy SW, Palmer AA et al. Malignant melanoma in childhood: a clinicopathologic study of 13 cases and comparison with Spitz nevi. World J. Surg.16(2), 179–185 (1992).
   PubMed Web of Science ®Google Scholar
• Wechsler J, Bastuji-Garin S, Spatz A et al. Reliability of the histopathologic diagnosis of malignant melanoma in childhood. Arch. Dermatol.138(5), 625–628 (2002).
   PubMedGoogle Scholar
• Barnhill RL. The spitzoid lesion: the importance of atypical variants and risk assessment. Am. J. Dermatopathol.28(1), 75–83 (2006).
   PubMed Web of Science ®Google Scholar
• Gelbard SN, Tripp JM, Marghoob AA et al. Management of Spitz nevi: a survey of dermatologists in the United States. J. Am. Acad. Dermatol.47(2), 224–230 (2002).
   PubMed Web of Science ®Google Scholar
• Herreid PA, Shapiro PE. Age distribution of Spitz nevus vs malignant melanoma. Arch. Dermatol.132(3), 352–353 (1996).
   PubMedGoogle Scholar
• Piepkorn M. On the nature of histologic observations: the case of the Spitz nevus. J. Am. Acad. Dermatol.32(2 Pt 1), 248–254 (1995).
   PubMed Web of Science ®Google Scholar
• Barnhill RL, Flotte TJ, Fleischli M, Perez-Atayde A. Cutaneous melanoma and atypical Spitz tumors in childhood. Cancer76(10), 1833–1845 (1995).
   PubMed Web of Science ®Google Scholar
• Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am. J. Pathol.157(3), 967–972 (2000).
   PubMed Web of Science ®Google Scholar
• Urso C, Borgognoni L, Saieva C et al. Sentinel lymph node biopsy in patients with ‘atypical Spitz tumors.’ a report on 12 cases. Hum. Pathol.37(7), 816–823 (2006).
   PubMed Web of Science ®Google Scholar
• Bastian BC. Molecular cytogenetics as a diagnostic tool for typing melanocytic tumors. Recent Results Cancer Res.160, 92–99 (2002).
   PubMedGoogle Scholar
• Conley J, Lattes R, Orr W. Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma). Cancer28(4), 914–936 (1971).
   PubMed Web of Science ®Google Scholar
• Whitaker DC, Argenyi Z, Smith AC. Desmoplastic malignant melanoma: rare and difficult to diagnose. J. Am. Acad. Dermatol.26(5 Pt 1), 704–709 (1992).
   PubMed Web of Science ®Google Scholar
• Smithers BM, McLeod GR, Little JH. Desmoplastic, neural transforming and neurotropic melanoma: a review of 45 cases. Aust. NZ J. Surg.60(12), 967–972 (1990).
   PubMedGoogle Scholar
• Lens MB, Newton-Bishop JA, Boon AP. Desmoplastic malignant melanoma: a systematic review. Br. J. Dermatol.152(4), 673–678 (2005).
   PubMed Web of Science ®Google Scholar
• Busam KJ. Cutaneous desmoplastic melanoma. Adv. Anat. Pathol.12(2), 92–102 (2005).
   PubMed Web of Science ®Google Scholar
• Hawkins WG, Busam KJ, Ben-Porat L et al. Desmoplastic melanoma: a pathologically and clinically distinct form of cutaneous melanoma. Ann. Surg. Oncol.12(3), 207–213 (2005).
   PubMed Web of Science ®Google Scholar
• Gyorki DE, Busam K, Panageas K, Brady MS, Coit DG. Sentinel lymph node biopsy for patients with cutaneous desmoplastic melanoma. Ann. Surg. Oncol.10(4), 403–407 (2003).
   PubMed Web of Science ®Google Scholar
• Argenziano G, Zalaudek I, Corona R et al. Vascular structures in skin tumors: a dermoscopy study. Arch. Dermatol.140(12), 1485–1489 (2004).
   PubMedGoogle Scholar
• Debarbieux S, Ronger-Salve S, Dalle S, Balme B, Thomas L. Dermoscopy of desmoplastic melanoma: report of six cases. Br. J. Dermatol.159(2), 360–363 (2008).
   PubMed Web of Science ®Google Scholar
• Thosani MK, Marghoob A, Chen CS. Current progress of immunostains in Mohs micrographic surgery: a review. Dermatol. Surg.34(12), 1621–1636 (2008).
   PubMed Web of Science ®Google Scholar
• Laveau F, Picot MC, Dereure O, Guilhou JJ, Guillot B. [Metastatic melanoma of unknown primary site]. Ann. Dermatol. Venereol.128(8–9), 893–898 (2001).
   PubMed Web of Science ®Google Scholar
• Lee CC, Faries MB, Wanek LA, Morton DL. Improved survival after lymphadenectomy for nodal metastasis from an unknown primary melanoma. J. Clin. Oncol.26(4), 535–541 (2008).
   PubMed Web of Science ®Google Scholar
• Giuliano AE, Cochran AJ, Morton DL. Melanoma from unknown primary site and amelanotic melanoma. Semin. Oncol.9(4), 442–447 (1982).
   PubMed Web of Science ®Google Scholar
• Paraskevas LR, Halpern AC, Marghoob AA. Utility of the Wood’s light: five cases from a pigmented lesion clinic. Br. J. Dermatol.152(5), 1039–1044 (2005).
   PubMed Web of Science ®Google Scholar
• Bories N, Dalle S, Debarbieux S, Balme B, Ronger-Savle S, Thomas L. Dermoscopy of fully regressive cutaneous melanoma. Br. J. Dermatol.158(6), 1224–1229 (2008).
   PubMed Web of Science ®Google Scholar
• Cormier JN, Xing Y, Feng L et al. Metastatic melanoma to lymph nodes in patients with unknown primary sites. Cancer106(9), 2012–2020 (2006).
   PubMed Web of Science ®Google Scholar
• Giacomel J, Zalaudek I, Mordente I, Nicolino R, Argenziano G. Never perform laser treatment of skin tumors with clinical ‘EFG’ criteria. J. Dtsch. Dermatol. Ges.6(5), 386–388 (2008).
   PubMed Web of Science ®Google Scholar
• Zabel RJ, Vinson RP, McCollough ML. Malignant melanoma arising in a seborrheic keratosis. J. Am. Acad. Dermatol.42(5 Pt 1), 831–833 (2000).
   PubMed Web of Science ®Google Scholar
• Figgener L, Runte C. Digital radiography and electronic data storage from the perspective of legal requirements for record keeping. J. Forensic Odontostomatol.21(2), 40–44 (2003).
   PubMedGoogle Scholar
• Scheinfeld NS, Flanigan K, Moshiyakhov M, Weinberg JM. Trends in the use of cameras and computer technology among dermatologists in New York city 2001–2002. Dermatol. Surg.29(8), 822–825 (2003).
   PubMed Web of Science ®Google Scholar
• Scheinfeld N. Photographic images, digital imaging, dermatology, and the law. Arch. Dermatol.140(4), 473–476 (2004).
   PubMedGoogle Scholar
• Nehal KS, Oliveria SA, Marghoob AA et al. Use of and beliefs about baseline photography in the management of patients with pigmented lesions: a survey of dermatology residency programmes in the United States. Melanoma Res.12(2), 161–167 (2002).
   PubMed Web of Science ®Google Scholar
• Keach E. Successful malpractice defense lies in the body of evidence. In: Dermatology Times (2006).
   Google Scholar
• Vestergaard ME, Macaskill P, Holt PE, Menzies SW. Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting. Br. J. Dermatol.159(3), 669–676 (2008).
   PubMed Web of Science ®Google Scholar
• Altman J. The National Association of Insurance Commissioners (NAIC) Medical Malpractice Closed Claim Study 1975–1978: a review of dermatologic claims. J. Am. Acad. Dermatol.5(6), 721–725 (1981).
   PubMed Web of Science ®Google Scholar
• Localio AR, Lawthers AG, Brennan TA et al. Relation between malpractice claims and adverse events due to negligence. Results of the Harvard Medical Practice Study III. N. Engl. J. Med.325(4), 245–251 (1991).
   PubMed Web of Science ®Google Scholar
• Witman AB, Park DM, Hardin SB. How do patients want physicians to handle mistakes? A survey of internal medicine patients in an academic setting. Arch. Intern. Med.156(22), 2565–2569 (1996).
   PubMed Web of Science ®Google Scholar
• Kittler H, Pehamberger H, Wolff K, Binder M. Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi. J. Am. Acad. Dermatol.43(3), 467–476 (2000).
   PubMed Web of Science ®Google Scholar
• Menzies SW, Gutenev A, Avramidis M, Batrac A, McCarthy WH. Short-term digital surface microscopic monitoring of atypical or changing melanocytic lesions. Arch. Dermatol.137(12), 1583–1589 (2001).
   PubMedGoogle Scholar
• Halpern AC. The use of whole body photography in a pigmented lesion clinic. Dermatol. Surg.26(12), 1175–1180 (2000).
   PubMed Web of Science ®Google Scholar
• Kovalyshyn I, Dusza SW, Siamas K, Halpern AC, Argenziano G, Marghoob A. A historical cohort study of melanoma detection patterns at a pigmented lesion clinic, 1998–2008. Presented at: Sixth International Symposium On Melanoma And Other Cutaneous Malignancies. NY, USA, 13–14 March 2009 (Abstract).
   Google Scholar
• Busam KJ, Charles C, Lohmann CM, Marghoob A, Goldgeier M, Halpern AC. Detection of intraepidermal malignant melanoma in vivo by confocal scanning laser microscopy. Melanoma Res.12(4), 349–355 (2002).
   PubMed Web of Science ®Google Scholar
• Guitera P, Pellacani G, Longo C, Seidenari S, Avramidis M, Menzies SW. In vivo reflectance confocal microscopy enhances secondary evaluation of melanocytic lesions. J. Invest. Dermatol.129(1), 131–138 (2009).
   PubMed Web of Science ®Google Scholar
• Marghoob AA, Swindle LD, Moricz CZ et al. Instruments and new technologies for the in vivo diagnosis of melanoma. J. Am. Acad. Dermatol.49(5), 777–797; quiz 798–779 (2003).
   PubMed Web of Science ®Google Scholar
• Langley RG, Walsh N, Sutherland AE et al. The diagnostic accuracy of in vivo confocal scanning laser microscopy compared to dermoscopy of benign and malignant melanocytic lesions: a prospective study. Dermatology215(4), 365–372 (2007).
   PubMed Web of Science ®Google Scholar
• Elbaum M, Kopf AW, Rabinovitz HS et al. Automatic differentiation of melanoma from melanocytic nevi with multispectral digital dermoscopy: a feasibility study. J. Am. Acad. Dermatol.44(2), 207–218 (2001).
   PubMed Web of Science ®Google Scholar
• Gutkowicz-Krusin D, Elbaum M, Jacobs A et al. Precision of automatic measurements of pigmented skin lesion parameters with a MelaFind™ multispectral digital dermoscope. Melanoma Res.10(6), 563–570 (2000).
   PubMed Web of Science ®Google Scholar
• Wolff T, Tai E, Miller T. Screening for skin cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann. Intern. Med.150(3), 194–198 (2009).
   PubMed Web of Science ®Google Scholar
• Warycha MA, Christos PJ, Mazumdar M et al. Changes in the presentation of nodular and superficial spreading melanomas over 35 years. Cancer113(12), 3341–3348 (2008).
   PubMed Web of Science ®Google Scholar
• Kashani-Sabet M, Rangel J, Torabian S et al. A multi-marker assay to distinguish malignant melanomas from benign nevi. Proc. Natl. Acad. Sci. USA106(15), 6268–6272 (2009).
   PubMed Web of Science ®Google Scholar